Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comorbidities in Heart Failure.

Haye H van der Wal1, Vincent M van Deursen1, Peter van der Meer1

  • 1Department of Cardiology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.

Handbook of Experimental Pharmacology
|April 7, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in biomarkers and molecular pathways according to age for patients with HFrEF.

Cardiovascular research·2020
Same author

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.

European journal of heart failure·2020
Same author

Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 study.

European journal of heart failure·2020
Same author

Drug development in oncology and devices-lessons for heart failure drug development and approval? a review.

Heart failure reviews·2020
Same author

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.

Cardiovascular research·2020
Same author

A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure.

Nutrients·2020

Chronic heart failure (HF) often co-occurs with other conditions, increasing patient illness and death. This study examines HF comorbidities, their impact, and the complex interactions involved.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Comorbidities are prevalent in chronic heart failure (HF) patients.
  • These co-existing conditions significantly increase morbidity, mortality, and reduce quality of life.

Purpose of the Study:

  • To describe the prevalence of high-impact comorbidities in chronic HF.
  • To analyze the impact of these comorbidities on patient morbidity and mortality.
  • To elucidate the pathophysiological processes and interactions between HF and comorbidities.

Main Methods:

  • Review of existing literature on chronic heart failure and comorbidities.
  • Analysis of prevalence data for key comorbidities in HF populations.
  • Exploration of pathophysiological mechanisms linking HF and common comorbidities.
Keywords:
AnemiaCognitive dysfunctionComorbiditiesDiabetes mellitusHeart failureHematinic deficienciesHyperkalemiaIron deficiencyRenal failureSleep apneaSleep-disordered breathing

Related Experiment Videos

Main Results:

  • Chronic HF is frequently associated with multiple high-impact comorbidities.
  • These comorbidities demonstrably worsen HF outcomes, including increased mortality.
  • Complex interactions, potentially involving inflammation, neurohormonal activation, and hemodynamic changes, exist between HF and comorbidities.

Conclusions:

  • Comorbidities represent a critical challenge in managing chronic heart failure.
  • Understanding the interplay between HF and comorbidities is essential for improving patient prognosis.
  • Further research into shared risk factors and pathophysiological pathways is warranted.